Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 12 tags : Fda save search
FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment
Published: 2021-08-12 (Crawled : 21:00) - fda.gov
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: -0.14%
H: 1.0%
C: -2.26%
treatment fda granted grant
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults
Published: 2021-08-12 (Crawled : 19:00) - prnewswire.com
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: -0.14%
H: 1.0%
C: -2.26%
fda fda approval approval sodium oxybate
AngioDynamics Receives FDA Approval for PRESERVE Study
Published: 2021-08-12 (Crawled : 19:00) - angiodynamics.com
ANGO | $6.26 2.29% 2.24% 480K
|
Health Technology
|
| O: 0.37%
H: 0.99%
C: -0.91%
fda fda approval approval
Allogene Therapeutics Receives FDA Orphan Drug Designation (ODD) for ALLO-715 for the Treatment of Multiple Myeloma (MM)
Published: 2021-08-12 (Crawled : 13:00) - globenewswire.com
ALLO | $3.48 0.58% 0.57% 2M
|
Health Technology
|
| O: 0.05%
H: 0.42%
C: -0.42%
treatment fda drug designation
Junshi Biosciences and Coherus Announce U.S. FDA Breakthrough Therapy Designation Granted for Toripalimab for 1st Line Treatment of Nasopharyngeal Carcinoma
Published: 2021-08-12 (Crawled : 12:15) - globenewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.21%
H: 1.55%
C: 1.47%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: 1.05%
H: 1.26%
C: 0.96%
treatment fda therapy breakthrough therapy grant designation
VTX-801 Receives U.S. FDA Fast Track Designation for the Treatment of Wilson Disease
Published: 2021-08-12 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.41%
H: 1.94%
C: 1.59%
disease treatment fda fda fast track fast track fast track designation designation
Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR™ Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery
Published: 2021-08-12 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.01%
H: 0.85%
C: 0.79%
CTSO | $0.8026 0.2% 0.2% 46K
|
Health Technology
|
| O: 5.13%
H: 2.35%
C: -2.44%
fda drug device iot cardio designation
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.